Skip to Content

Join the 'Allopurinol' group to help and get support from people like you.

Allopurinol News

FDA Approves Duzallo (lesinurad and allopurinol) for Hyperuricemia in Patients with Uncontrolled Gout

Posted 21 Aug 2017 by Drugs.com

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 21, 2017-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced Duzallo was approved by the U.S. Food and Drug Administration (FDA) as a once-daily oral treatment for hyperuricemia associated with gout in patients who have not achieved target serum uric acid (sUA) levels with a medically appropriate daily dose of allopurinol alone. Duzallo is not ...

Common Gout Drug Tied to Lower Risk of Early Death in Study

Posted 28 Mar 2014 by Drugs.com

FRIDAY, March 28, 2014 – A drug often used to treat gout may reduce the risk of premature death in patients with this common form of arthritis, according to a new study. Previous research has associated gout with an increased risk of early death. This study examined how allopurinol – the most widely used medication for gout – might affect that risk. Allopurinol causes a potentially fatal ...

40-Year-Old Gout Drug Shows Promise Against Angina

Posted 8 Jun 2010 by Drugs.com

MONDAY, June 7 – A new British study suggests that a standard treatment for gout, already in use for four decades, could be an effective and less expensive alternative to conventional drugs targeting chronic stable angina. Following work with 65 heart disease patients between the ages of 18 and 85, the research team noted that six weeks of high doses (600 milligrams per day) of the gout drug ...

Ask a Question

Further Information

Related Condition Support Groups

Gout, Heart Failure, Congestive Heart Failure, Calcium Oxalate Calculi with Hyperuricosuria, Hyperuricemia Secondary to Chemotherapy, Cardiothoracic Surgery, High Risk Percutaneous Transluminal Angioplasty, Leishmaniasis, Mania, Reactive Perforating Collangenosis, Urinary Tract Stones

Related Drug Support Groups

Zyloprim, Lopurin, Aloprim

Allopurinol Patient Information at Drugs.com